GO:0036024 protein C inhibitor-TMPRSS7 complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036024 describes a heterodimeric protein complex formed by protein C inhibitor (SERPINA5) and transmembrane protease serine 7 (TMPRSS7), in which complex formation inhibits the serine protease activity of TMPRSS7.
• The complex is a cellular_component term, meaning it is defined by its physical assembly rather than by an enzymatic reaction or a biological pathway.
• SERPINA5 is a multifunctional serpin best known for inhibiting activated protein C (APC) and other serine proteases of the coagulation and fibrinolytic systems.
• The protein C pathway, which includes APC and its inhibitor SERPINA5, is a central anticoagulant and cytoprotective system.
• APC-SERPINA5 complexes are measurable in human plasma and have been studied as biomarkers in vascular disease, including peripheral arterial disease and aortic aneurysms.
• Studying GO:0036024 requires tools that resolve protein-protein interactions and protease activity, such as co-immunoprecipitation, proximity ligation, and CRISPR-based gene editing.
Description
GO:0036024, protein C inhibitor-TMPRSS7 complex, is a Gene Ontology cellular_component term that defines a specific heterodimeric assembly between protein C inhibitor (encoded by SERPINA5) and transmembrane protease serine 7 (TMPRSS7). Protein C inhibitor is a plasma serpin that regulates several serine proteases, most prominently activated protein C (APC), and its inhibitory function is central to the anticoagulant protein C pathway. The protein C pathway itself is a well-characterized system in which APC, generated from its zymogen protein C, downregulates coagulation and exerts cytoprotective effects. The formation of a complex between protein C inhibitor and a target serine protease is the molecular event through which inhibition occurs, and such complexes have been detected in human plasma as markers of protease-inhibitor interaction. The protein C inhibitor-TMPRSS7 complex therefore represents a specific instance of serpin-protease complex biology, linking a soluble inhibitor to a transmembrane protease. For researchers, GO:0036024 provides a precise annotation target for studies of protease regulation at the cell surface, for the interpretation of protein interaction datasets, and for the design of experiments that test whether SERPINA5 or TMPRSS7 perturbations alter complex formation. Because the term is defined by complex assembly and not by a downstream pathway, it is particularly useful for functional genomics screens that score protein-protein interactions or protease activity. Understanding this complex also has translational relevance, since SERPINA5-containing complexes have been associated with vascular pathology in clinical studies.
protein C inhibitor-TMPRSS7 complex At A Glance
| GO ID | GO:0036024 |
|---|---|
| GO term | protein C inhibitor-TMPRSS7 complex |
| Ontology | cellular_component |
| Synonym | PCI-TMPRSS7 complex; plasma serine protease inhibitor-TMPRSS7 complex; protein C inhibitor-matriptase-3 complex; protein C inhibitor-transmembrane protease serine 7 complex; serpin A5-TMPRSS7 complex; SERPINA5-TMPRSS7 complex |
| Major function | Heterodimeric assembly of SERPINA5 and TMPRSS7 that inhibits the serine protease activity of TMPRSS7 |
| Complex type | Heterodimer (two distinct polypeptide chains) |
| Key components | SERPINA5 (protein C inhibitor) and TMPRSS7 (transmembrane protease serine 7) |
| Functional consequence | Inhibition of TMPRSS7 serine protease activity |
| Related pathway | Protein C anticoagulant and cytoprotective pathway |
What Is GO:0036024?
In plain terms, GO:0036024 describes a two-protein assembly: protein C inhibitor (SERPINA5) bound to transmembrane protease serine 7 (TMPRSS7). The QuickGO definition states that this heterodimeric complex contains SERPINA5 and TMPRSS7, and that formation of the complex inhibits the serine protease activity of TMPRSS7. The term is annotated under the cellular_component ontology, meaning it is a physical entity within a cell rather than a process or a molecular function. Its synonyms include PCI-TMPRSS7 complex, plasma serine protease inhibitor-TMPRSS7 complex, protein C inhibitor-matriptase-3 complex, protein C inhibitor-transmembrane protease serine 7 complex, serpin A5-TMPRSS7 complex, and SERPINA5-TMPRSS7 complex. The inhibitory outcome is consistent with the canonical behavior of serpins, which form stable complexes with their target proteases and thereby block proteolytic activity.
Why Is protein C inhibitor-TMPRSS7 complex Important in Cell Biology?
GO:0036024 matters because it captures a specific molecular interaction that connects the protein C inhibitor system to a transmembrane serine protease. Protein C inhibitor is a multifunctional serpin that regulates proteases in coagulation, fibrinolysis, and reproduction, and its complexes with target proteases are detectable in human plasma and have been linked to vascular disease states. The protein C pathway as a whole is a major anticoagulant and cytoprotective system, and its dysregulation is relevant to thrombosis and inflammation. By annotating the SERPINA5-TMPRSS7 heterodimer as a distinct cellular component, GO:0036024 gives researchers a precise handle for investigating how a soluble serpin controls a membrane-anchored protease, and for interpreting interaction proteomics and functional screens that perturb either partner.
• Provides a defined annotation for a specific serpin-protease heterodimer, enabling precise functional genomics interpretation.
• Links SERPINA5, a multifunctional inhibitor of activated protein C and other serine proteases, to a transmembrane protease target.
• Connects to the protein C pathway, a central anticoagulant and cytoprotective system in human physiology.
• Supports biomarker research, since APC-protein C inhibitor complexes have been measured in peripheral arterial disease and aortic aneurysms.
• Offers a model for studying serpin mechanism, because serpins act by forming stable inhibitory complexes with their target proteases.
• Enables CRISPR-based tests of whether SERPINA5 or TMPRSS7 loss alters complex formation and protease activity.
• Relevant to vascular biology and hemostasis research, where protein C inhibitor complexes are studied as markers of protease activation.
• Useful for AI-driven knowledge graphs that require exact GO identifiers and component-level relationships.
• Supports drug-target hypothesis generation at the interface of coagulation and membrane proteolysis.
• Facilitates cross-species comparison of serpin-protease complexes in hemostasis research.
Structure and Composition of protein C inhibitor-TMPRSS7 complex
SERPINA5: the protein C inhibitor subunit
In simple terms: SERPINA5 is the inhibitor half of the complex.
SERPINA5 encodes protein C inhibitor, a plasma serpin that inhibits activated protein C and other serine proteases and is a key regulator within the protein C system. Serpins such as protein C inhibitor function by presenting a reactive center loop that engages the target protease, leading to stable complex formation and loss of protease activity. In the context of GO:0036024, SERPINA5 is the subunit that binds TMPRSS7 and blocks its serine protease activity.
TMPRSS7: the transmembrane protease subunit
In simple terms: TMPRSS7 is the protease half of the complex.
TMPRSS7 is a transmembrane serine protease, and the QuickGO definition of GO:0036024 specifies that its serine protease activity is inhibited upon formation of the heterodimer with protein C inhibitor. Transmembrane serine proteases are membrane-anchored enzymes, which positions TMPRSS7 for regulation at the cell surface. The complex therefore represents a membrane-proximal regulatory event in which a soluble serpin engages a membrane-bound protease.
Heterodimer assembly
In simple terms: The two proteins join to form a two-part complex.
GO:0036024 is defined as a heterodimeric protein complex containing SERPINA5 and TMPRSS7. Heterodimeric means the complex is built from two distinct polypeptide chains, one from each gene. Assembly of this complex is the event that produces inhibition of TMPRSS7, consistent with the general serpin mechanism in which inhibitor-protease complex formation is coupled to protease inactivation.
Relationship to the protein C pathway
In simple terms: This complex is part of the broader protein C inhibitor story.
Protein C inhibitor is a component of the protein C pathway, which regulates coagulation and exerts cytoprotective effects through activated protein C. Complexes between activated protein C and protein C inhibitor have been detected in patient plasma and studied as biological markers in vascular disease. The SERPINA5-TMPRSS7 complex extends this framework by defining a distinct cellular component in which protein C inhibitor engages a transmembrane protease rather than APC.
Detection of serpin-protease complexes
In simple terms: Complexes like this can be measured in samples.
Serpin-protease complexes are stable enough to be detected in biological fluids, as demonstrated by measurements of activated protein C-protein C inhibitor complex in peripheral arterial disease and aortic aneurysm studies. This precedent supports experimental strategies that detect the SERPINA5-TMPRSS7 complex using complex-specific antibodies, co-immunoprecipitation, or proximity-based assays. Such detection is essential for validating that GO:0036024 is present in a given cell or tissue context.
Key Genes Involved in GO:0036024 protein C inhibitor-TMPRSS7 complex
The following genes and proteins are directly or contextually relevant to GO:0036024 and to the protein C inhibitor system in which it operates.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SERPINA5 | Encodes protein C inhibitor, the serpin subunit of the complex | Core component of GO:0036024; inhibits serine proteases including APC |
| TMPRSS7 | Encodes transmembrane protease serine 7, the protease subunit | Core component of GO:0036024; its activity is inhibited by complex formation |
| PROC | Encodes protein C, the zymogen of activated protein C | Central to the protein C pathway that protein C inhibitor regulates |
| PROCR | Encodes the endothelial protein C receptor | Component of the protein C pathway |
| F5 | Encodes coagulation factor V, a cofactor in coagulation | Relevant to coagulation context in which protein C inhibitor acts |
| F8 | Encodes coagulation factor VIII | Relevant to coagulation cascade context |
| SERPINC1 | Encodes antithrombin, another anticoagulant serpin | Comparative serpin biology and hemostasis |
| F2 | Encodes prothrombin, a serine protease zymogen | Coagulation protease context for serpin inhibition |
| PLG | Encodes plasminogen, precursor of the serine protease plasmin | Fibrinolytic context relevant to protein C inhibitor |
| F12 | Encodes factor XII, a serine protease zymogen | Contact activation protease context |
| KLKB1 | Encodes plasma kallikrein, a serine protease | Serine protease context for serpin inhibition |
| TMPRSS2 | Encodes a transmembrane serine protease | Comparative transmembrane serine protease biology |
| TMPRSS3 | Encodes a transmembrane serine protease | Comparative transmembrane serine protease biology |
| TMPRSS4 | Encodes a transmembrane serine protease | Comparative transmembrane serine protease biology |
| TMPRSS6 | Encodes matriptase-2, a transmembrane serine protease | Comparative matriptase family biology |
| ST14 | Encodes matriptase, a transmembrane serine protease | Matriptase family context; protein C inhibitor-matriptase-3 is a synonym of GO:0036024 |
| APOH | Encodes beta-2-glycoprotein I, a plasma protein | Plasma protein context in coagulation research |
| SERPINE1 | Encodes plasminogen activator inhibitor-1, a serpin | Comparative serpin biology in hemostasis |
How Is protein C inhibitor-TMPRSS7 complex Regulated?
The formation and stability of the protein C inhibitor-TMPRSS7 complex are governed by the general principles of serpin-protease regulation. Serpins such as protein C inhibitor form inhibitory complexes with target serine proteases, and this complex formation is the mechanism by which protease activity is controlled. The broader protein C pathway is regulated by the generation of activated protein C from its zymogen and by the availability of cofactors and receptors, including the endothelial protein C receptor. Because protein C inhibitor circulates in plasma and its complexes with activated protein C are measurable in patients, the abundance of inhibitor-protease complexes can reflect the activation state of the corresponding protease. For GO:0036024 specifically, regulation can be conceptualized as the balance between TMPRSS7 protease availability and SERPINA5 inhibitor availability, with complex formation shifting TMPRSS7 toward an inhibited state.
protein C inhibitor-TMPRSS7 complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SERPINA5 | Vascular disease and coagulation imbalance | SERPINA5 knockout cell line with protease activity assays |
| TMPRSS7 | Membrane protease dysregulation | TMPRSS7 knockout or point-mutant cell line |
| PROC | Thrombotic and inflammatory vascular disease | PROC knockout or point-mutation models |
| PROCR | Protein C pathway dysfunction | PROCR knockout endothelial cell models |
| SERPINA5 | Peripheral arterial disease and aortic aneurysm biomarker context | Patient plasma complex measurement studies |
Vascular disease and biomarker studies
Complexes between activated protein C and protein C inhibitor have been evaluated as biological markers in vascular disease. In peripheral arterial disease, activated protein C-protein C inhibitor complex levels were studied as a potential indicator of coagulation activation. In aortic aneurysms, the activated protein C-protein C inhibitor complex has been proposed as a new biological marker. These findings establish a clinical research context in which protein C inhibitor-containing complexes are measured in patient samples, providing a rationale for investigating the SERPINA5-TMPRSS7 complex in vascular biology.
Coagulation and thrombosis
The protein C pathway is a major anticoagulant system, and its dysfunction is relevant to thrombotic disease. Protein C inhibitor regulates activated protein C and other serine proteases, placing it within the hemostatic balance. Blood coagulation as a whole is a tightly regulated process in which serine protease cascades are controlled by inhibitors. The SERPINA5-TMPRSS7 complex belongs to this broader landscape of protease-inhibitor interactions that shape coagulation and vascular homeostasis.
Comparative and veterinary perspectives
Endogenous anticoagulants, including serpins and the protein C system, have been reviewed in comparative and veterinary medicine contexts. This comparative view is useful because it highlights conserved principles of serpin-based protease regulation that can inform studies of the SERPINA5-TMPRSS7 complex across species.
From protein C inhibitor-TMPRSS7 complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of SERPINA5 abolish the protein C inhibitor-TMPRSS7 complex? | SERPINA5 knockout cell line |
| Does loss of TMPRSS7 abolish the complex and alter protease activity? | TMPRSS7 knockout cell line |
| Does a specific SERPINA5 reactive-center mutation prevent complex formation? | SERPINA5 point-mutation knock-in |
| Can the complex be detected with a tagged subunit? | Tagged knock-in of SERPINA5 or TMPRSS7 |
| Does overexpression of SERPINA5 increase inhibition of TMPRSS7? | SERPINA5 overexpression cell model |
| Which interaction partners co-precipitate with the complex? | Affinity purification with tagged knock-in followed by mass spectrometry |
How to Study the protein C inhibitor-TMPRSS7 complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical association of SERPINA5 and TMPRSS7 | Validation of GO:0036024 in cell lysates |
| Affinity purification mass spectrometry | Protein interaction partners of the complex | Discovery of additional complex components |
| Protease activity assay | TMPRSS7 serine protease activity | Testing inhibition by SERPINA5 |
| Proximity ligation assay | In situ proximity of the two subunits | Localization of complex formation |
| RNA sequencing | Expression of SERPINA5 and TMPRSS7 | Identifying cell contexts for complex formation |
| Quantitative proteomics | Protein abundance and complexed serpin levels | Translational and biomarker-oriented studies |
| CRISPR knockout screening | Genes required for complex formation or activity | Functional genomics of protease regulation |
| Western blotting | Complex-specific band detection | Confirming serpin-protease complex formation |
Co-immunoprecipitation and affinity purification
Because GO:0036024 is defined as a physical heterodimer, co-immunoprecipitation is a direct way to test whether SERPINA5 and TMPRSS7 associate in a given cell type. Tagged knock-in of either subunit enables affinity purification followed by mass spectrometry to identify additional interacting proteins. This approach parallels the detection of serpin-protease complexes in biological samples, where stable complexes can be captured with specific antibodies.
Protease activity assays
The functional readout of GO:0036024 is inhibition of TMPRSS7 serine protease activity. Activity assays using fluorogenic or chromogenic substrates can quantify TMPRSS7 activity in the presence or absence of SERPINA5. Comparing wild-type and SERPINA5-knockout cells provides a test of whether complex formation is required for TMPRSS7 inhibition, consistent with the serpin mechanism of protease inactivation.
Proximity ligation and imaging
Proximity ligation assays and fluorescence imaging can visualize the SERPINA5-TMPRSS7 complex in situ and localize it relative to the plasma membrane, since TMPRSS7 is a transmembrane protease. These methods complement biochemical detection and can reveal whether complex formation occurs at the cell surface or in intracellular compartments.
Transcriptomics and proteomics
RNA sequencing and quantitative proteomics can measure SERPINA5 and TMPRSS7 expression across cell types and conditions, helping to identify contexts in which GO:0036024 is likely to form. Because protein C inhibitor is a plasma protein and its complexes have been measured in patient samples, proteomic workflows that detect complexed serpins are relevant to translational studies.
How CRISPR Can Be Used to Study GO:0036024 protein C inhibitor-TMPRSS7 complex
Knockout
CRISPR knockout of SERPINA5 or TMPRSS7 provides a clean genetic test of GO:0036024. Loss of SERPINA5 should reduce or eliminate the complex and may increase TMPRSS7 activity, while loss of TMPRSS7 removes the protease subunit entirely. These models are foundational for assigning causality in protease-inhibitor biology.
Point Mutation
Point mutations in SERPINA5 can be introduced to test the reactive-center loop residues that mediate serpin-protease complex formation. Because serpins rely on a precise conformational mechanism to trap their target protease, targeted point mutations can distinguish binding from inhibition. Similar mutations in TMPRSS7 can probe its catalytic serine and substrate-binding pocket.
Knock-in
Tagged knock-in of SERPINA5 or TMPRSS7 enables detection and purification of the endogenous complex without overexpression artifacts. A fluorescent or epitope tag allows imaging of complex localization and affinity capture for interaction proteomics, directly supporting the cellular_component definition of GO:0036024.
Overexpression
Overexpression of SERPINA5 or TMPRSS7 can amplify complex formation and make downstream phenotypes easier to measure. Overexpression models are useful for dose-response studies of protease inhibition and for testing whether increased inhibitor levels shift TMPRSS7 activity, complementing loss-of-function approaches.
How EDITGENE Supports protein C inhibitor-TMPRSS7 complex Research
Researchers studying protein C inhibitor-TMPRSS7 complex-related genes often need to determine whether a candidate gene is causally involved in complex formation, protease inhibition, or downstream vascular phenotypes. Establishing causality requires clean genetic models in which SERPINA5, TMPRSS7, or related pathway genes are precisely perturbed and the resulting molecular and cellular consequences are measured.
Contact EDITGENE today to design your custom CRISPR model for protein C inhibitor-TMPRSS7 complex research.
Frequently Asked Questions About protein C inhibitor-TMPRSS7 complex
What is GO:0036024?
GO:0036024 is the Gene Ontology cellular_component term for the protein C inhibitor-TMPRSS7 complex, a heterodimer of SERPINA5 and TMPRSS7 whose formation inhibits TMPRSS7 serine protease activity.
What is the protein C inhibitor-TMPRSS7 complex?
It is a two-protein assembly in which protein C inhibitor (SERPINA5) binds transmembrane protease serine 7 (TMPRSS7) and blocks its serine protease activity.
What genes are involved in the protein C inhibitor-TMPRSS7 complex?
The core genes are SERPINA5, which encodes protein C inhibitor, and TMPRSS7, which encodes the transmembrane protease. Related pathway genes include PROC and PROCR.
What is the function of SERPINA5?
SERPINA5 encodes protein C inhibitor, a plasma serpin that inhibits activated protein C and other serine proteases and is a key regulator in the protein C system.
What is TMPRSS7?
TMPRSS7 is a transmembrane serine protease; in GO:0036024 its serine protease activity is inhibited when it forms a complex with protein C inhibitor.
Why is the protein C inhibitor-TMPRSS7 complex important?
It provides a defined molecular link between a soluble serpin and a membrane protease, and it connects to the protein C pathway, a central anticoagulant and cytoprotective system.
How can I study GO:0036024 in the lab?
Common approaches include co-immunoprecipitation, proximity ligation, protease activity assays, and CRISPR knockout or knock-in of SERPINA5 and TMPRSS7.
Is the protein C inhibitor-TMPRSS7 complex related to disease?
Protein C inhibitor complexes with activated protein C have been studied as biomarkers in peripheral arterial disease and aortic aneurysms, providing clinical context for protein C inhibitor-containing complexes.
What are the synonyms of GO:0036024?
Synonyms include PCI-TMPRSS7 complex, plasma serine protease inhibitor-TMPRSS7 complex, protein C inhibitor-matriptase-3 complex, serpin A5-TMPRSS7 complex, and SERPINA5-TMPRSS7 complex.
How do CRISPR models help study the protein C inhibitor-TMPRSS7 complex?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to test whether SERPINA5 or TMPRSS7 is required for complex formation and protease inhibition.
Conclusion
GO:0036024 defines the protein C inhibitor-TMPRSS7 complex, a heterodimeric cellular component in which SERPINA5 binds and inhibits the transmembrane protease TMPRSS7. The term sits within the broader biology of the protein C pathway and serpin-protease regulation, areas with established clinical relevance in coagulation and vascular disease. Because the complex is defined by a physical interaction with a functional consequence, it is well suited to CRISPR-based causal studies and to interaction proteomics. Researchers can use knockout, point-mutation, knock-in, and overexpression models to determine how SERPINA5 and TMPRSS7 control complex formation and protease activity in health and disease.
References
- 1. Kubier A et al.. 2012. Endogenous anticoagulants.. Top Companion Anim Med 27(2):81-7 PMID: 23031460
- 2. Blomstrand D et al.. 2010. Activated protein C-protein C inhibitor complex in peripheral arterial disease.. Ann Vasc Surg 24(5):588-95 PMID: 20409682
- 3. Norris LA. 2003. Blood coagulation.. Best Pract Res Clin Obstet Gynaecol 17(3):369-83 PMID: 12787532
- 4. Esmon CT. 2003. The protein C pathway.. Chest 124(3 Suppl):26S-32S PMID: 12970121
- 6. Kölbel T et al.. 2006. Activated protein C-protein C inhibitor complex: a new biological marker for aortic aneurysms.. J Vasc Surg 43(5):935-9 PMID: 16678686
- 7. Espana F et al.. 2005. The multifunctional protein C system.. Curr Med Chem Cardiovasc Hematol Agents 3(2):119-31 PMID: 15853699
- 8. Dahlbäck B et al.. 2005. The anticoagulant protein C pathway.. FEBS Lett 579(15):3310-6 PMID: 15943976
